The economic cost of arthritis in New Zealand in 2018

This report, commissioned by Arthritis New Zealand, highlights the staggering expenses associated with the direct, indirect, and for the first time, wellbeing costs of arthritis.

The role of SLC2A9 Variants in Hyperuricemia and Gout

Gout is a debilitating arthritis caused by elevated levels of serum urate in the blood (hyperuricemia). The prevalence of gout is on the rise worldwide with particularly high rates of the disease present in Māori and Pacific populations in New Zealand (9.3-13.9% of Māori men...

Lipoproteins and Hyperlipoproteinemia: Links to Gout

Gout and cardiovascular disease are both complex and multi-factorial with genetic predisposition and environmental triggers. Not only do both have high co-morbidity with other metabolic conditions, gout patients have high risk for cardiovascular events. Māori and Pacific populations have high risk for both gout and...

Testing the Vitamin D3 metabolic gene variants for association with gout in the New Zealand case-control sample-sets

Gout is a common disease caused by immune response to monosodium urate (MSU) crystal deposition in articular or periarticular tissues and in the renal tract after chronic hyperuricemia (uric acid levels exceeding 7mg/dL). Gout generally progresses in three clinical stages: asymptomatic hyperuricemia (elevated serum urate...

Negotiating Barriers: An Investigation of Early Access to Rheumatology Services for Patients with Inflammatory Arthritis in the Wellington Region

Inflammatory arthritis (IA) is term that encompasses a range of auto-immune joint diseases that can cause severe pain, joint erosion and disability. Although there is no cure for these IAs, early treatment beginning within three months of symptom onset with disease-modifying anti-rheumatic drugs can significantly...

Investigation of the Genetic Link Between the Metabolic Diseases Gout and Type 2 Diabetes

Gout is associated with various co-morbidities including insulin resistance and type 2 diabetes. Gout and type 2 diabetes are strongly linked to the individual components of metabolic syndrome. There may be shared pathogenic pathways between gout and type 2 diabetes in which insulin resistance, obesity...
Briefing paper

Musculoskeletal conditions as underlying and associated causes of death 2013

Summary Musculoskeletal conditions are a range of conditions that affect the bones, muscles and connective tissues. In this bulletin, the musculoskeletal conditions reported include osteoarthritis; rheumatoid arthritis; osteoporosis; back problems; gout and other inflammatory arthropathies (in ammation of one or more joints); and lupus and...

Counting the cost: the current and future burden of arthritis

A major new report shows the growing multi-billion dollar costs of arthritis to the economy, individuals and to the healthcare system and how relatively small investments could yield savings of more than $170 million a year. Key findings of the report include: • There are...
Fact sheet

Rheumatoid arthritis: musculoskeletal fact sheet

This fact sheet summarises information from the AIHW's online musculoskeletal compendium. Summary Rheumatoid arthritis is a chronic disease marked by inflammation of the joints, most often affecting the hand joints and both sides of the body at the same time. It can also affect the...
Fact sheet

Osteoarthritis: musculoskeletal fact sheet

This fact sheet summarises information from the AIHW's online musculoskeletal compendium. Summary Osteoarthritis is a degenerative condition mostly affecting the joints such as hips, knees and ankles. The main symptoms include pain, stiffness and limited joint movement which get worse over time. Normally, healthy cartilage...